Mitsubishi UFJ Kokusai Asset Management Co. Ltd. decreased its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 17.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,826 shares of the medical equipment provider’s stock after selling 6,186 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Zimmer Biomet Holdings were worth $3,701,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Enterprise Financial Services Corp raised its stake in Zimmer Biomet Holdings by 0.3% in the second quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock worth $340,000 after buying an additional 9 shares during the last quarter. Alpha Windward LLC raised its stake in Zimmer Biomet Holdings by 1.1% in the first quarter. Alpha Windward LLC now owns 1,651 shares of the medical equipment provider’s stock worth $202,000 after buying an additional 18 shares during the last quarter. Sandy Spring Bank raised its stake in Zimmer Biomet Holdings by 1.7% in the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock worth $149,000 after buying an additional 20 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in Zimmer Biomet Holdings by 2.7% in the first quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock worth $102,000 after buying an additional 22 shares during the last quarter. Finally, Cleararc Capital Inc. raised its stake in Zimmer Biomet Holdings by 0.5% in the first quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock worth $598,000 after buying an additional 25 shares during the last quarter. Hedge funds and other institutional investors own 83.62% of the company’s stock.

Shares of Zimmer Biomet Holdings, Inc. (ZBH) opened at 111.70 on Friday. The firm has a market capitalization of $22.59 billion, a P/E ratio of 31.81 and a beta of 1.20. The stock has a 50 day moving average price of $124.93 and a 200 day moving average price of $121.26. Zimmer Biomet Holdings, Inc. has a 12-month low of $95.63 and a 12-month high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.10 by $0.02. The firm had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. Zimmer Biomet Holdings’s revenue was up 1.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.02 EPS. Equities analysts anticipate that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 22nd will be given a $0.24 dividend. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 annualized dividend and a dividend yield of 0.86%. Zimmer Biomet Holdings’s payout ratio is 27.59%.

TRADEMARK VIOLATION NOTICE: “Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Sells 6,186 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)” was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.dailypolitical.com/2017/08/13/mitsubishi-ufj-kokusai-asset-management-co-ltd-sells-6186-shares-of-zimmer-biomet-holdings-inc-nysezbh.html.

A number of analysts recently weighed in on the stock. Royal Bank Of Canada restated an “outperform” rating and set a $140.00 target price on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Citigroup Inc. upped their target price on shares of Zimmer Biomet Holdings from $108.00 to $130.00 and gave the stock a “neutral” rating in a research note on Friday, June 9th. Jefferies Group LLC restated a “buy” rating and set a $148.00 target price on shares of Zimmer Biomet Holdings in a research note on Friday, June 30th. Wells Fargo & Company restated a “market weight” rating on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Finally, Piper Jaffray Companies restated a “buy” rating and set a $141.00 target price on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $136.90.

In other news, insider Sang Yi sold 17,731 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, June 12th. The stock was sold at an average price of $124.56, for a total value of $2,208,573.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Tony W. Collins sold 16,986 shares of Zimmer Biomet Holdings stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $121.74, for a total value of $2,067,875.64. The disclosure for this sale can be found here. 1.07% of the stock is currently owned by company insiders.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.